Skip to main content

Bruker Shares Continue to Climb After CEO Laukien Buys $1.1M Worth of Stock

NEW YORk, May 18 (GenomeWeb News) - Bruker Biosciences CEO Frank Laukien bought more than $1.1 million worth of his company's shares since May 10, sending the stock up 12.7 percent to $3.99 in mid-afternoon trading today.

 

According to Insidercow.com, which tracks insider trading at public companies, Laukien bought 277,430 shares of Bruker stock at prices between $3.60 and $3.00 per share between May 10 and May 17.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.